{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:31:46Z","timestamp":1774362706851,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cervical cancer has become a major public health challenge in developing countries with a reported age-standardised incidence rate of about 17.9\/100,000\/year and lifetime risks approaching 1 in 20 in some settings. Evidence indicates that HIV-seropositive women are 2 to 12 times more likely to develop precancerous lesions that lead to cervical cancer than HIV-negative women. There is a lack of rigorous evidence on which treatment methods are being utilised for HIV-positive women, and this review aims to synthesise available evidence on treatment modalities for both cervical neoplasia and cervical cancer in HIV-seropositive women in developing countries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic review guided by a published protocol was conducted. Online databases including MEDLINE\/PubMed, Embase, CINAHL and Emerald (via EBSCOhost), PsycINFO, Cochrane Library, and health databases, which cover developing countries (3ie Systematic Reviews, WHO library and databases, World Bank website), were searched for published articles. Additional articles were found through citation, reference list tracking, and grey literature. Study design, treatment category, geographic country\/region, and key outcomes for each included article were documented and summarised.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirteen research articles from sub-Saharan Africa, Asia, and South America were included. Eight (61.5%) articles focused on the treatment of cervical cancer with the remaining five (38.5%) assessed cervical neoplasia treatment. The available cervical cancer treatments, radiotherapy, chemotherapy, chemoradiation, and surgery are effective for HIV-seropositive patients, and these are the same treatments for HIV-negative patients. Both cryotherapy and LEEP are effective in reducing CIN2+ among HIV-seropositive women, and a choice between the treatments might be based on available resources and expertise. Radiation, chemotherapy, concurrent treatment using radiotherapy and chemotherapy, and surgery have shown the possibility of effectiveness among HIV-seropositive women. Cervical cancer stage, immunosuppressive level including those on HAART, and multisystem toxicities due to treatment are associated with treatment completion, prognostic, and survival outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Treatment of cervical cancer is based on the stage of cancer, and poor outcomes in most developing countries might be due to a lack of optimal treatment regimen. Those infected with HIV were younger and had advanced cervical cancer as compared to those who were HIV-negative. Facilitation and putting HIV-infected people on life-long ART is of importance and has been found to have a positive impact on cervical cancer treatment response. Research on precancerous lesions and cervical cancer management of HIV-seropositive patients focusing on the quality of life of those treated; the effectiveness of the treatment method considering CD4+ count and ART is required.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p>PROSPERO CRD42018095707<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13643-020-01345-2","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T20:02:12Z","timestamp":1586548932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Treatment of pre- and confirmed cervical cancer in HIV-seropositive women from developing countries: a systematic review"],"prefix":"10.1186","volume":"9","author":[{"given":"Witness","family":"Mapanga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingairai A.","family":"Feresu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"Girdler-Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,10]]},"reference":[{"key":"1345_CR1","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1158\/1055-9965.1574.13.10","volume":"13","author":"TS Shields","year":"2004","unstructured":"Shields TS, Brinton LA, Burk RD, et al. A case-control study of risk factors for invasive cervical cancer among U.S women exposed to oncogenic types of human papillomavirus. Cancer Epidemiology Biomakers Prevention. 2004;13:1574\u201382.","journal-title":"Cancer Epidemiology Biomakers Prevention"},{"issue":"1","key":"1345_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","volume":"16","author":"EM Burd","year":"2003","unstructured":"Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1):1\u201317. https:\/\/doi.org\/10.1128\/CMR.16.1.1-17.2003.","journal-title":"Clin Microbiol Rev."},{"key":"1345_CR3","volume-title":"Human Papillomavirus and related cancers, HPV information centre","author":"Word Health Organisation., Institut Catala\u2019 d\u2019Oncologia (ICO)","year":"2010","unstructured":"Word Health Organisation., Institut Catala\u2019 d\u2019Oncologia (ICO). Human Papillomavirus and related cancers, HPV information centre. Gevena: WHO\/ICO; 2010."},{"issue":"12","key":"1345_CR4","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsagu\u00e9 X, Ferrer E, Bosch FX, de Sanjos\u00e9 S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010 Dec 15;202(12):1789\u201399.","journal-title":"J Infect Dis."},{"key":"1345_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bpobgyn.2004.10.002","volume":"19","author":"ZM Chirenje","year":"2005","unstructured":"Chirenje ZM. HIV and cancer of the cervix. Best Pract Res Clin Obstet Gynaecol. 2005;19:269\u201376.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"1345_CR6","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1086\/520022","volume":"45","author":"S Franceschi","year":"2007","unstructured":"Franceschi S, Jaffe H. Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy. Clin Infect Dis. 2007;45(4):510\u20133. https:\/\/doi.org\/10.1086\/520022.","journal-title":"Clin Infect Dis"},{"key":"1345_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.gore.2017.07.009","volume":"21","author":"RG Ghebre","year":"2017","unstructured":"Ghebre RG, Grover S, Xu MJ, Chuang LT, Simonds H. Cervical cancer control in HIV-infected women: past, present and future. Gynecol Oncol Rep. 2017;21:101\u20138.","journal-title":"Gynecol Oncol Rep"},{"issue":"2","key":"1345_CR8","first-page":"319","volume":"19","author":"AD Shrestha","year":"2018","unstructured":"Shrestha AD, Neupane D, Vedsted P, Kallestrup P. Cervical cancer prevalence, incidence and mortality in low and middle income countries: a systematic review. Asian Pac J Cancer Prev. 2018;19(2):319\u201324.","journal-title":"Asian Pac J Cancer Prev."},{"issue":"2","key":"1345_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijgo.2015.07.038","volume":"132","author":"N Santesso","year":"2016","unstructured":"Santesso N, Mustafa RA, Sch\u00fcnemann HJ, Arbyn M, Blumenthal PD, Cain J, Chirenje M, et al. World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer. Int J Gynaecol Obstet. 2016;132(2):252\u20138.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"1345_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/LGT.0000000000000165","volume":"20","author":"JS Coleman","year":"2016","unstructured":"Coleman JS, Cespedes MS, Cu-Uvin S, Kosgei RJ, Maloba M, Anderson J, et al. An insight into cervical cancer screening and treatment capacity in sub Saharan Africa. J Low Genit Tract Dis. 2016;20(1):31\u20137.","journal-title":"J Low Genit Tract Dis."},{"key":"1345_CR11","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ygyno.2009.06.001","volume":"114","author":"L Elit","year":"2009","unstructured":"Elit L, Fyles AW, Devries MC, et al. Follow-up for women after treatment for cervical cancer: a systematic review. Gynecol Oncol. 2009;114:528.","journal-title":"Gynecol Oncol"},{"key":"1345_CR12","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN Clinical practice guidelines in oncology. http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp."},{"key":"1345_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12905-016-0306-6","volume":"16","author":"S Finocchario-Kessler","year":"2016","unstructured":"Finocchario-Kessler S, Wexler C, Maloba M, Mabachi N, Ndikum-Moffor F, Bukusi E. Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective. BMC Womens Health. 2016;16:29.","journal-title":"BMC Womens Health."},{"issue":"4","key":"1345_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/ewjm.175.4.231","volume":"175","author":"J Sherris","year":"2001","unstructured":"Sherris J, Herdman C, Elias C. Cervical cancer in the developing world. West J Med. 2001;175(4):231\u20133.","journal-title":"West J Med."},{"issue":"3","key":"1345_CR15","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s10461-013-0480-6","volume":"18","author":"FE Fletcher","year":"2014","unstructured":"Fletcher FE, Vidrine DJ, Tami-Maury I, Danysh HE, King RM, Buchberg M, Arduino RC, Gritz ER. Cervical cancer screening adherence among HIV-positive female smokers from a comprehensive HIV clinic. AIDS Behav. 2014;18(3):544\u201354.","journal-title":"AIDS Behav."},{"issue":"1","key":"1345_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13643-017-0484-9","volume":"6","author":"W Mapanga","year":"2017","unstructured":"Mapanga W, Elhakeem A, Feresu SA, Maseko F, Chipato T. Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol. Syst Rev. 2017;6(1):91. https:\/\/doi.org\/10.1186\/s13643-017-0484-9.","journal-title":"Syst Rev"},{"issue":"7","key":"1345_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","journal-title":"PLoS Med."},{"key":"1345_CR18","unstructured":"NIH Study Quality Assessment Tools. Available at https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools [Accessed 2 October 2018]."},{"key":"1345_CR19","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Quality Assessment Scale. Available at http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp [Accessed 11 Oct 2016]."},{"issue":"11","key":"1345_CR20","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1002\/cncr.26639","volume":"118","author":"HM Simonds","year":"2012","unstructured":"Simonds HM, Wright JD, du Toit N, Neugut AI, Jacobson JS. Completion of and early response to chemoradiation among HIV-positive and HIV-negative patients with locally advanced cervical carcinoma in South Africa. Cancer. 2012;118(11):2971\u20139.","journal-title":"Cancer"},{"issue":"1","key":"1345_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.radonc.2004.11.006","volume":"74","author":"SK Shrivastava","year":"2005","unstructured":"Shrivastava SK, Engineer R, Rajadhyaksha S, Dinshaw KA. HIV infection and invasive cervical cancers, treatment with radiation therapy: toxicity and outcome. Radiother Oncol. 2005;74(1):31\u20135.","journal-title":"Radiother Oncol"},{"issue":"2","key":"1345_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ygyno.2005.10.006","volume":"100","author":"P Gichangi","year":"2006","unstructured":"Gichangi P, Bwayo J, Estambale B, Rogo K, Njuguna E, Ojwang S, Temmerman M. HIV impact on acute morbidity and pelvic tumor control following radiotherapy for cervical cancer. Gynecol Oncol. 2006;100(2):405\u201311.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1345_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/20742835.2016.1239356","volume":"8","author":"S Mdletshea","year":"2016","unstructured":"Mdletshea S, Munkupab H, Lishimpib K. Acute toxicity in cervical cancer HIV-positive vs. HIV-negative patients treated by radical chemo-radiation in Zambia. South Afr J Gynaecol Oncol. 2016;8(2):37\u201341.","journal-title":"South Afr J Gynaecol Oncol"},{"issue":"3","key":"1345_CR24","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.7314\/APJCP.2016.17.3.1123","volume":"17","author":"K Boupaijit","year":"2016","unstructured":"Boupaijit K, Suprasert P. Survival outcomes of advanced and recurrent cervical cancer patients treated with chemotherapy: experience of Northern Tertiary Care Hospital in Thailand. Asian Pac J Cancer Prev. 2016;17(3):1123\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"1345_CR25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/QAD.0000000000001367","volume":"31","author":"MP Ferreira","year":"2017","unstructured":"Ferreira MP, Coghill AE, Chaves CB, Bergmann A, Thuler LC, Soares EA, Pfeiffer RM, Engels EZ, Soares MA. Outcomes of cervical cancer among HIV-infected and uninfected women treated at the Brazilian National Institute of Cancer (2001-2013). AIDS. 2017;31(4):523\u201331.","journal-title":"AIDS"},{"key":"1345_CR26","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/j.1525-1438.2007.00936.x","volume":"17","author":"M Moodley","year":"2007","unstructured":"Moodley M. Radical hysterectomy for cervical cancer amongst women infected with the human immunodeficiency virus. Int J Gynecol Cancer. 2007;17:1264\u20135.","journal-title":"Int J Gynecol Cancer"},{"key":"1345_CR27","doi-asserted-by":"publisher","unstructured":"Kietpeerakool C, Srisomboon J, Suprasert P, Phongnarisorn C, Charoenkwan K, Cheewakriangkrai C, Siriaree S, Tantipalakorn C, Pantusart A. Outcomes of loop electrosurgical excision procedure for cervical neoplasia in human immunodeficiency virus\u2013infected women. Int J Gynecol Cancer. 2006;16:1082\u20138. https:\/\/doi.org\/10.1111\/j.1525-1438.2006.00518.x.","DOI":"10.1111\/j.1525-1438.2006.00518.x"},{"key":"1345_CR28","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/QAI.0000000000001539","volume":"76","author":"C Firnhaber","year":"2017","unstructured":"Firnhaber C, Swarts A, Goeieman B, Rakhombe N, Mulongo M, Williamson AL, Michelow P, Ramotshela S, Faesen M, Levin S, Wilkin T. Cryotherapy reduces progression of cervical intraepithelial neoplasia grade 1 in South African HIV-infected women: a randomized, controlled trial. J Acquir Immune Defic Syndr. 2017;76:532\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"1345_CR29","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/AOG.0b013e31822b0991","volume":"118","author":"VG Woo","year":"2011","unstructured":"Woo VG, Cohen CR, Bukusi EA, Huchko M. Loop electrosurgical excision procedure: safety and tolerability among human immunodeficiency virus-positive Kenyan women. Obstet Gynecol. 2011;118(3):554\u20139.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1345_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ygyno.2019.01.023","volume":"153","author":"MH Einstein","year":"2019","unstructured":"Einstein MH, Ndlovu N, Lee J, Stier EA, Kotzen J, Garg M, Whitney K, Krown SE. Cisplatin and radiation therapy in HIV-positive women with locally advanced cervical cancer in sub-Saharan Africa: a phase II study of the AIDS malignancy consortium. Gynecologic Oncology. 2019;153(1):20\u20135.","journal-title":"Gynecologic Oncology."},{"key":"1345_CR31","doi-asserted-by":"publisher","first-page":"183.e1","DOI":"10.1016\/j.ajog.2017.03.022","volume":"217","author":"JS Smith","year":"2017","unstructured":"Smith JS, Sanusi B, Swarts A, Faesen M, Levin S, Goeieman B, Ramotshela S, Rakhombe N, Williamson AL, Michelow P, Omar T, Hudgens MG, Firnhaber C. A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV-seropositive women from Johannesburg, South Africa. Am J Obstet Gynecol. 2017;217:183.e1\u201311.","journal-title":"Am J Obstet Gynecol"},{"key":"1345_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijgo.2008.11.006","volume":"105","author":"C Kietpeerakool","year":"2009","unstructured":"Kietpeerakool C, Suprasert P, Srisomboon J. Outcomes of loop electrosurgical excision procedure for HIV-positive women in a low-resource outpatient setting. Int J Gynecol Obstet. 2009;105:10\u20133.","journal-title":"Int J Gynecol Obstet"},{"issue":"16","key":"1345_CR33","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1200\/JCO.2005.05.4908","volume":"24","author":"M Bower","year":"2006","unstructured":"Bower M, Mazhar D, Stebbing J. Should cervical cancer be an acquired immunodeficiency syndrome-defining cancer? J Clin Oncol. 2006;24(16):2417\u20139.","journal-title":"J Clin Oncol"},{"issue":"15","key":"1345_CR34","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1200\/JCO.2007.15.2348","volume":"26","author":"C Oehler-Janne","year":"2008","unstructured":"Oehler-Janne C, Huguet F, Provencher S, et al. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy. J Clin Oncol. 2008;26(15):2550\u20137..","journal-title":"J Clin Oncol"},{"key":"1345_CR35","unstructured":"Chemoradiotherapy for Cervical Cancer MetaAnalysis Collaboration (CCCMAC). Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: Individual patient data metaanalysis. Cochrane Database Syst Rev. 2010;1:CD008285."},{"key":"1345_CR36","doi-asserted-by":"publisher","first-page":"4830","DOI":"10.1016\/j.vaccine.2018.02.023","volume":"36","author":"N Tan","year":"2018","unstructured":"Tan N, Sharma M, Winer R, Galloway D, Rees H, Barnabas RV. Model-estimated effectiveness of single dose 9-valent HPV vaccination for HIV-positive and HIV-negative females in South Africa. Vaccine. 2018;36:4830\u20136.","journal-title":"Vaccine."},{"issue":"9","key":"1345_CR37","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1093\/cid\/ciu094","volume":"58","author":"H Masur","year":"2014","unstructured":"Masur H, Brooks JT, Benson CA, Holmes KK, Pau AK, Kaplan JE. Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: updated guidelines from the centers for disease control and prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2014;58(9):1308\u201311.","journal-title":"Clin Infect Dis."}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-020-01345-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-020-01345-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-020-01345-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T01:15:59Z","timestamp":1666314959000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-020-01345-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,10]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1345"],"URL":"https:\/\/doi.org\/10.1186\/s13643-020-01345-2","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,10]]},"assertion":[{"value":"29 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This systematic review is part of a bigger research project. Ethical approval for the project was obtained from the Research Ethics Committee of the Faculty of Health Sciences, University of Pretoria (ethics reference number: 146\/2016)","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}